pioglitazone has been researched along with inositol in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (10.00) | 18.2507 |
| 2000's | 9 (45.00) | 29.6817 |
| 2010's | 7 (35.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Kitaoka, H | 2 |
| Fujimoto, S; Ikeda, H; Ishida, H; Kajikawa, M; Kato, S; Mizuno, N; Mukai, E; Nishimura, M; Odaka, H; Seino, Y; Yamada, Y | 1 |
| Flight, IH; Lord, JM; Norman, RJ | 1 |
| Kawagoe, Y; Koide, H; Matsuda, T; Nakamura, T; Ogawa, H; Sekizuka, K; Takahashi, Y | 1 |
| Mori, M; Oh-I, S; Ohtani, KI; Okada, S; Shimizu, H; Tsuchiya, T | 1 |
| Aso, Y; Inukai, T; Matsumoto, S; Matsutomo, R; Suetsugu, M; Takebayashi, K; Wakabayashi, S; Yamamoto, R | 1 |
| Abe, M; Kaizu, K; Kikuchi, F; Matsumoto, K | 1 |
| Mori, M; Negishi, M; Proks, P; Shimomura, K; Shimomura, Y | 1 |
| Feng, Y; Hirasawa, Y; Kyuki, K; Matsui, Y; Nagamatsu, T; Ohtsu, S; Sakai, T; Toyoshi, T; Yamane, K | 1 |
| Akishita, M; Lisanti, MP; Okamoto, L; Okamoto, T | 1 |
| Fujitaka, K; Iwasaka, T; Iwasaki, M; Jo, F; Jo, H; Nishikawa, M; Nomura, E; Otani, H | 1 |
| Alarcon-Aguilar, FJ; Almanza-Perez, JC; Angeles-Mejia, S; Banderas-Dorantes, TR; Blancas-Flores, G; Diaz-Flores, M; Fortis-Barrera, A; Gomez, J; Jasso, I; Roman-Ramos, R; Zamilpa-Alvarez, A | 1 |
| Nagai, Y | 1 |
| Fukase, H; Harigai, M; Iida, S; Ikeda, S; Kasahara, N; Miyata, K; Ohba, Y; Saito, T; Takano, Y; Terao, K | 1 |
| Balen, AH; Morley, LC; Norman, RJ; Tang, T; Yasmin, E | 1 |
| Bae, J; Cha, BS; Kang, ES; Lee, BW; Lee, JY; Lee, M; Lee, YH; Shin, E | 1 |
| Ehtesham, E; Habib, SH; Hassan, S; Malik, MO; Rauf, B; Shah, M | 1 |
4 review(s) available for pioglitazone and inositol
| Article | Year |
|---|---|
[Alpha-glucosidase inhibitor and insulin sensitizer combination therapy in NIDDM].
Topics: Acarbose; Animals; Chromans; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Inositol; Insulin Resistance; Pioglitazone; Thiazoles; Thiazolidinediones; Trisaccharides; Troglitazone | 1997 |
[Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].
Topics: Acarbose; Animals; Biguanides; Chromans; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Inositol; Insulin Resistance; Pioglitazone; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Troglitazone | 2002 |
Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.
Topics: Anovulation; Chromans; Female; Humans; Hypoglycemic Agents; Inositol; Metformin; Ovulation Induction; Pioglitazone; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone | 2003 |
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Topics: Abortion, Spontaneous; Anovulation; Clomiphene; Female; Humans; Hypoglycemic Agents; Infertility, Female; Inositol; Insulin Resistance; Live Birth; Metformin; Ovulation Induction; Pioglitazone; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones | 2017 |
9 trial(s) available for pioglitazone and inositol
| Article | Year |
|---|---|
Effect of pioglitazone on carotid intima-media thickness and arterial stiffness in type 2 diabetic nephropathy patients.
Topics: Albuminuria; Blood Pressure; Blood Urea Nitrogen; Carotid Arteries; Creatinine; Diabetes Mellitus, Type 2; Double-Blind Method; Enzyme Inhibitors; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inositol; Male; Middle Aged; Pioglitazone; Protein Precursors; Sulfonylurea Compounds; Thiazolidinediones | 2004 |
Pioglitazone increases circulating adiponectin levels and subsequently reduces TNF-alpha levels in Type 2 diabetic patients: a randomized study.
Topics: Adiponectin; Administration, Oral; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Inositol; Leptin; Male; Middle Aged; Pioglitazone; Plasminogen Activator Inhibitor 1; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2006 |
Comparison of the effects of pioglitazone and voglibose on circulating total and high-molecular-weight adiponectin, and on two fibrinolysis inhibitors, in patients with Type 2 diabetes.
Topics: Adiponectin; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hypoglycemic Agents; Inositol; Insulin Resistance; Male; Molecular Weight; Pioglitazone; Plasminogen Activator Inhibitor 1; Thiazolidinediones; Treatment Outcome | 2007 |
Combination therapy of pioglitazone with voglibose improves glycemic control safely and rapidly in Japanese type 2-diabetic patients on hemodialysis.
Topics: Aged; Asian People; Blood Glucose; Case-Control Studies; Demography; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inositol; Insulin Resistance; Japan; Lipids; Male; Pioglitazone; Renal Dialysis; Thiazolidinediones | 2007 |
Alpha glucosidase inhibitor voglibose can prevent pioglitazone-induced body weight gain in Type 2 diabetic patients.
Topics: Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Inositol; Male; Middle Aged; Pioglitazone; Thiazolidinediones; Treatment Outcome; Weight Gain | 2008 |
Switch to oral hypoglycemic agent therapy from insulin injection in patients with type 2 diabetes.
Topics: Administration, Oral; Aged; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inositol; Insulin; Male; Middle Aged; Pioglitazone; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome | 2008 |
Comparison of metabolic profile and adiponectin level with pioglitazone versus voglibose in patients with type-2 diabetes mellitus associated with metabolic syndrome.
Topics: Adiponectin; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Inositol; Insulin Resistance; Metabolic Syndrome; Metabolome; Obesity; Pioglitazone; Thiazolidinediones | 2011 |
A Pharmacokinetic/Pharmacodynamic Drug-Drug Interaction Study of Tofogliflozin (a New SGLT2 Inhibitor) and Selected Anti-Type 2 Diabetes Mellitus Drugs.
Topics: 1-Deoxynojirimycin; Adult; Benzhydryl Compounds; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Interactions; Glucose; Glucosides; Healthy Volunteers; Humans; Hypoglycemic Agents; Inositol; Male; Metformin; Middle Aged; Nateglinide; Phenylalanine; Pioglitazone; Sitagliptin Phosphate; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Thiazolidinediones; Urine; Young Adult | 2016 |
Treatment with combined resveratrol and myoinositol ameliorates endocrine, metabolic alterations and perceived stress response in women with PCOS: a double-blind randomized clinical trial.
Topics: Adiponectin; Adult; Female; Follicle Stimulating Hormone; Humans; Inositol; Insulin; Luteinizing Hormone; Metformin; Obesity; Pioglitazone; Polycystic Ovary Syndrome; Resveratrol; Stress, Psychological; Testosterone; Young Adult | 2023 |
7 other study(ies) available for pioglitazone and inositol
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Beneficial effect of long-term combined treatment with voglibose and pioglitazone on pancreatic islet function of genetically diabetic GK rats.
Topics: Animals; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Fasting; Glucose Tolerance Test; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Inositol; Insulin; Insulin Secretion; Islets of Langerhans; Male; Pioglitazone; Rats; Rats, Mutant Strains; Rats, Wistar; Thiazoles; Thiazolidinediones; Triglycerides | 1998 |
Involvement of hyperglycemia in deposition of aggregated protein in glomeruli of diabetic mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus; Glucose; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Hyperglycemia; Hypoglycemic Agents; Inositol; Insulin; Kidney Glomerulus; Lysine; Male; Mice; Mice, Inbred ICR; Pioglitazone; Serum Albumin; Serum Albumin, Bovine; Thiazolidinediones | 2008 |
Antioxidant and anti-inflammatory effects of a hypoglycemic fraction from Cucurbita ficifolia Bouché in streptozotocin-induced diabetes mice.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Blood Glucose; Cucurbita; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fruit; Glutathione; Hypoglycemic Agents; Inflammation Mediators; Inositol; Liver; Male; Malondialdehyde; Mice; Mice, Inbred Strains; Oxidative Stress; Phytotherapy; Pioglitazone; Plant Extracts; Thiazolidinediones | 2012 |
[Fixed-dose combination].
Topics: Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Inositol; Isoindoles; Metformin; Pioglitazone; Piperidines; Sulfonylurea Compounds; Thiazolidinediones; Uracil | 2015 |
The effects of the voglibose on non-alcoholic fatty liver disease in mice model.
Topics: Animals; Diet, High-Fat; Disease Models, Animal; Fructose; Glucose; Glycoside Hydrolase Inhibitors; Inositol; Lipogenesis; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Pioglitazone | 2022 |